Table 1.

Baseline characteristics

Characteristic	N = 15
Sex	No. (%)
Male	1 (7)
Female	14 (93)
Age	Year
Median (range)	52 (34–70)
Type of systemic sclerosis	No. (%)
Limited cutaneous	15 (100)
Duration of systemic sclerosis	Year
Median (range)	4 (1–10)
Duration of Raynaud’s phenomenon	Year
Median (range)	10 (2–26)
Immunosuppressive agents	No. (%)
Current use
Methotrexate	4 (27)
Former use
Methotrexate	1 (7)
Cyclophosphamide	1 (7)
Azathioprine	1 (7)
Never	8 (53)
Concomitant treatment	No. (%)
Calcium-channel blockers	10 (67)
Angiotensin converting enzyme inhibitors	6 (40)
Ketanserin	5 (33)
Statins	2 (13)
Aspirin	6 (40)
Coumarin	2 (13)